NDC properties for "ATryn 1 UNT Injection" (RxCUI 1661566)
About this data
The tables show NDC propoerties for ATryn 1 UNT Injection with the RxCUI 1661566
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for ATryn 1 UNT Injection (RxCUI 1661566)
| MMSL_CODE | BD24895 |
|---|---|
| RxCUI | 1661566 |
| Prescribable Synonym | ATryn 1 UNT Injection |
| RXNAV_STR | ATryn 1 UNT Injection |
| RxNorm Name | antithrombin alfa 1 UNT Injection [ATryn] |
| RxNorm Synonym | ATryn 1 UNT Injection |
| Related queries | Interactions (for RxCUI 1661566) |
NDC Properties
NDC Item 42976012101
| NDC 9 | 42976-121 |
|---|---|
| NDC 10 | 42976-121-01 |
| NDC Item | 42976012101 |
| BLA | BLA125284 |
| FDA SPL set id | 584304 |
| Labeler | rEVO Biologics, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2015-06-30 |
| Marketing effective time low | 2009-05-06 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 42976-121 |
NDC Item 42976012102
| NDC 9 | 42976-121 |
|---|---|
| NDC 10 | 42976-121-02 |
| NDC Item | 42976012102 |
| Packaging | 1 VIAL in 1 CARTON (42976-121-02) / 3 mL in 1 VIAL |
| BLA | BLA125284 |
| FDA SPL set id | 584304 |
| Labeler | rEVO Biologics, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2015-06-30 |
| Marketing effective time low | 2009-05-06 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 42976-121 |
NDC Item 42976012101
| NDC 9 | 42976-121 |
|---|---|
| NDC 10 | 42976-121-01 |
| NDC Item | 42976012101 |
| BLA | BLA125284 |
| FDA SPL set id | 584304 |
| Labeler | rEVO Biologics, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2015-06-30 |
| Marketing effective time low | 2009-05-06 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 42976-121 |
NDC Item 42976012102
| NDC 9 | 42976-121 |
|---|---|
| NDC 10 | 42976-121-02 |
| NDC Item | 42976012102 |
| Packaging | 1 VIAL in 1 CARTON (42976-121-02) / 3 mL in 1 VIAL |
| BLA | BLA125284 |
| FDA SPL set id | 584304 |
| Labeler | rEVO Biologics, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2015-06-30 |
| Marketing effective time low | 2009-05-06 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 42976-121 |